Skip to main content
    S

    Sensus Healthcare Inc (SRTS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.89
    -0.04 (-1.37%)

    Market Cap: $47.58M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    62%(24/39)
    Avg Surprise
    -29.37%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.04
    Range$-0.08 - $0.02
    3 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$-0.05+7.3%
    60d ago$-0.05+7.3%
    30d ago$-0.06+31.6%
    7d ago$-0.06+31.6%
    Current$-0.04
    Revenue Consensus
    $7M
    Range$5M - $9M
    4 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.50
    Range$-0.56 - $-0.40
    3 analysts
    Revenue Consensus
    $3M
    Range$62000 - $5M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.50---
    Sep 26EST
    		-$-0.04---
    Jun 26
    Reported Aug 13
    		$-0.18$-0.11-63.64%Miss-200.0%
    Mar 26
    Reported May 7
    		$-0.16$-0.11-45.45%Miss+0.0%
    Dec 25
    Reported Feb 12
    		$-0.19$-0.05-280.00%Miss-311.1%
    Sep 25
    Reported Nov 6
    		$-0.06$-0.11+45.45%Beat-185.7%
    Jun 25
    Reported Aug 7
    		$-0.06$0.01-700.00%Miss-160.0%
    Mar 25
    Reported May 15
    		$-0.16$0.04-500.00%Miss-214.3%
    Dec 24
    Reported Feb 5
    		$0.09$0.12-25.00%Miss-65.4%
    Sep 24
    Reported Nov 14
    		$0.07$-0.01+800.00%Beat+177.8%
    Jun 24
    Reported Aug 8
    		$0.10$0.03+233.33%Beat+600.0%
    Mar 24
    Reported May 9
    		$0.14$-0.04+450.00%Beat+216.7%
    Dec 23
    Reported Feb 8
    		$0.26$0.14+85.71%Beat+52.9%
    Sep 23
    Reported Nov 9
    		$-0.09$-0.02-350.00%Miss-181.8%
    Jun 23
    Reported Aug 3
    		$-0.02N/A+75.00%Beat-109.5%
    Mar 23
    Reported May 3
    		$-0.12$0.13-192.31%Miss-112.4%
    Dec 22
    Reported Feb 9
    		$0.17$0.23-26.09%Miss-46.9%
    Sep 22
    Reported Nov 3
    		$0.11$0.13-15.38%Miss+1000.0%
    Jun 22
    Reported Aug 4
    		$0.21$0.13+61.54%Beat+1150.0%
    Mar 22
    Reported May 5
    		$0.97$0.40+142.50%Beat+1485.7%
    Dec 21
    Reported Feb 10
    		$0.32$0.16+100.00%Beat+1500.0%
    Sep 21
    Reported Nov 4
    		$0.01$-0.02+150.00%Beat+107.1%
    Jun 21
    Reported Aug 5
    		$-0.02N/A+66.67%Beat+87.5%
    Mar 21
    Reported May 6
    		$-0.07$-0.11+36.36%Beat+68.2%
    Dec 20
    Reported Feb 25
    		$0.02N/A+118.18%Beat-66.7%
    Sep 20
    Reported Nov 5
    		$-0.14$-0.14+0.00%Beat-250.0%
    Jun 20
    Reported Aug 6
    		$-0.16$-0.19+15.79%Beat-1700.0%
    Mar 20
    Reported May 7
    		$-0.22$-0.07-214.29%Miss-69.2%
    Dec 19
    Reported Feb 13
    		$0.06$0.03+100.00%Beat+500.0%
    Sep 19
    Reported Nov 6
    		$-0.04$-0.03-33.33%Miss-33.3%
    Jun 19
    Reported Aug 8
    		$0.01N/A+125.00%Beat+125.0%
    Mar 19
    Reported May 9
    		$-0.13$-0.03-333.33%Miss-62.5%
    Dec 18
    Reported Feb 14
    		$0.01$-0.01+200.00%Beat+133.3%
    Sep 18
    Reported Nov 1
    		$-0.03$-0.06+50.00%Beat+57.1%
    Jun 18
    Reported Aug 2
    		$-0.04$-0.05+20.00%Beat+33.3%
    Mar 18
    Reported May 3
    		$-0.08$-0.03-166.67%Miss+33.3%
    Dec 17
    Reported Feb 1
    		$-0.03N/A+62.50%Beat-1300.0%
    Sep 17
    Reported Nov 2
    		$-0.07$-0.07+0.00%Beat-
    Jun 17
    Reported Aug 3
    		$-0.06N/A+53.85%Beat-
    Mar 17
    Reported May 4
    		$-0.12$0.01-1300.00%Miss-
    Dec 16
    Reported Feb 2
    		$0.00N/A+108.33%Beat-

    Key Metrics

    Valuation
    P/E Ratio-4.90EV/EBITDAN/A
    Price/FCF-6.82xFCF Yield-14.65%
    Profitability
    Profit Margin-88.40%Operating Margin-138.90%
    ROE-34.80%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage-8.68x
    Current Ratio8.71xQuick Ratio4.44x
    Trading Statistics
    Beta1.19Avg Volume22.81K
    52-Week High$5.4952-Week Low$2.66

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.95
    SMA 20$2.99
    SMA 50$3.10
    SMA 200$3.64
    EMA 10$2.95
    EMA 20$3.00
    EMA 50$3.06
    EMA 200$3.44

    MACD

    Line: -0.05Signal: -0.05Hist: -0.00

    ADX

    ADX: 9.9+DI: 11.4-DI: 14.7

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$3.04

    Bollinger Bands

    Upper Band$3.13
    Lower Band$2.86
    %B Position906%(Upper)
    Band Width0.12

    RSI (14-Day)

    Neutral
    39.8

    Momentum Oscillators

    Stoch %K11.9
    Stoch %D19.1
    Williams %R-100.0
    ROC (10d)-5.9%
    Momentum-0.18
    CCI (20d)-109.3
    MFI (14d)48.7

    Volatility Measures

    ATR (14d)$0.12(4.3%)
    StdDev (20d)0.07
    Hist Vol28.3%(Moderate)

    Volume Flow

    VWAP$2.93
    OBV52.5K
    AD Line-245.8K
    CMF (20d)-0.321

    Volume Metrics

    Avg Vol (20d)23.1K
    Vol Ratio0.8x
    VWMA (20d)$2.99

    Pivot Points

    R3$3.06
    R2$3.03
    R1$2.98
    Pivot Point$2.96
    S1$2.90
    S2$2.88
    S3$2.83

    Advanced Oscillators

    TSI-14.33
    Ultimate Osc24.4
    KST-64.33

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$2.29M$3.39M$4.94M$6.88M$7.32M$8.34M$13.07M$8.84M$9.24M$10.66M$12.57M$3.90M
    Cost of Revenue$1.52M$2.40M$3.04M$4.17M$4.41M$3.99M$5.96M$3.60M$3.82M$4.00M$4.74M$1.91M
    Gross Profit$769,000$991,000$1.90M$2.71M$2.90M$4.35M$7.11M$5.24M$5.42M$6.66M$7.83M$1.99M
    Operating Expenses$3.95M$5.35M$5.05M$5.28M$4.85M$7.00M$5.38M$3.75M$3.44M$3.77M$2.25M$3.88M
    R&D$1.11M$1.59M$1.88M$1.82M$1.47M$2.61M$1.56M$863,000$866,000$926,000$675,000$1.08M
    SG&A$1.79M$2.04M$1.76M$1.92M$1.99M$2.21M$2.42M$1.57M$1.58M$1.58M$952,000$1.51M
    Operating Income$-3,180,000$-4,358,000$-3,149,000$-2,569,000$-1,943,000$-2,646,000$1.73M$1.50M$1.98M$2.89M$5.58M$-1,895,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$277,000
    Interest Expense$-117,000$-125,000$-156,000$-160,000$-183,000$-184,000$-230,000$-279,000$-209,000$-214,000$0$0
    Income Before Tax$-3,063,000$-4,233,000$-2,993,000$-2,409,000$-1,760,000$-2,462,000$1.96M$1.77M$2.19M$3.10M$5.81M$-1,576,000
    Income Tax Expense$5.69M$-1,607,000$174,000$-1,466,000$-723,000$110,000$410,000$559,000$579,000$827,000$1.60M$-125,000
    Net Income$-8,749,000$-2,626,000$-3,167,000$-943,000$-1,037,000$-2,572,000$1.55M$1.22M$1.61M$2.27M$4.21M$-1,451,000
    EBITDA$-3,033,000$-4,200,000$-2,985,000$-2,410,000$-1,785,000$-2,501,000$1.86M$1.60M$2.06M$3.00M$5.68M$-1,747,000
    EBIT$-3,180,000$-4,358,000$-3,149,000$-2,569,000$-1,943,000$-2,646,000$1.73M$1.50M$1.98M$2.89M$5.58M$-1,853,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SRTS

    News

    Q2 2026 Sensus Healthcare Inc Earnings Call Transcript

    Sensus Healthcare Inc. experienced a significant revenue decline in Q2 2026 due to delayed equipment orders caused by third-party financing issues. Despite this, the company is seeing strengthened commercial momentum...

    GuruFocus•10/7/26•Somewhat-Bearish

    Sensus Healthcare, Inc. (SRTS) Stock Price, News, Quote & History

    This article provides a detailed financial overview of Sensus Healthcare, Inc. (SRTS), including its stock price, historical data...

    Yahoo! Finance Canada•9/29/26•Neutral

    Sensus Healthcare, Inc. (NASDAQ:SRTS) Given Average Rating of "Moderate Buy" by Brokerages

    Sensus Healthcare (NASDAQ:SRTS) has received a "Moderate Buy" consensus rating from six analysts, with an average 12-month price target of $5.83 against its recent price of $3.12. Despite this positive rating...

    MarketBeat•9/18/26•Neutral

    Sensus Healthcare Launches Treat Skin Cancer to Empower Patients Navigating Non-Melanoma Skin Cancer

    Sensus Healthcare Inc. (NASDAQ: SRTS) has launched "Treat Skin Cancer," a comprehensive public awareness and patient education campaign. This initiative aims to guide individuals through all phases of a non-melanoma skin...

    EIN Presswire•9/15/26•Bullish

    Sensus Healthcare Stock Price Forecast. Should You Buy SRTS?

    Sensus Healthcare Inc (SRTS) has been downgraded to a "Hold/Accumulate" rating by StockInvest.us, with a technical score of 0.96. The stock experienced a 0.94% drop on September 8, 2026...

    StockInvest.us•9/6/26•Neutral

    SRTS Valuation and Fair Value

    P/E
    -4.9x
    Forward P/E
    21.4x
    P/FCF
    -6.8x
    PEG
    0.0x
    P/B
    1.3x
    See GNG's fair value

    SRTS Profitability: Margins, ROIC and FCF

    Gross margin
    36.4%
    Operating margin
    -138.9%
    Net margin
    -88.4%
    ROE
    -34.8%
    FCF margin
    -39.8%
    FCF yield
    -14.7%

    SRTS Competitors

    CompanyTicker
    Werewolf Therapeutics IncHOWL
    ImageneBio, Inc.IMA
    ETHZilla CorporationETHZ
    Hyperion DeFi, Inc.HYPD
    Precision Optics Corporation, Inc. Common stockPOCI
    LAVA Therapeutics NVLVTX
    Elicio Therapeutics Inc.ELTX
    Celularity IncCELU

    Sector: Healthcare

    SRTS Analyst Ratings

    Consensus
    Buy
    Analysts
    4
    Strong Buy
    1
    Buy
    3
    Hold
    0
    Sell
    0
    Strong Sell
    0

    SRTS Bull Case vs Bear Case

    Bear case

    • SRTS has a -88.4% net profit margin.
    • SRTS beat EPS estimates in 25.0% of its last 8 reported quarters.
    • SRTS's quarterly revenue changed -68.7% year over year.

    SRTS Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -96.1%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.04
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Frequently Asked Questions About SRTS

    Does SRTS pay dividends?

    Sensus Healthcare Inc (SRTS) does not currently pay a regular dividend.

    What is SRTS's market cap?

    Sensus Healthcare Inc (SRTS) has a market capitalization of $47.58M with a current stock price of $2.89.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In